• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

星形胶质细胞反应影响了淀粉样蛋白-β对临床前阿尔茨海默病中 tau 病理的影响。

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.

机构信息

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

Graduate Program in Biological Sciences-Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

出版信息

Nat Med. 2023 Jul;29(7):1775-1781. doi: 10.1038/s41591-023-02380-x. Epub 2023 May 29.

DOI:10.1038/s41591-023-02380-x
PMID:37248300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10353939/
Abstract

An unresolved question for the understanding of Alzheimer's disease (AD) pathophysiology is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) individuals do not develop detectable downstream tau pathology and, consequently, clinical deterioration. In vitro evidence suggests that reactive astrocytes unleash Aβ effects in pathological tau phosphorylation. Here, in a biomarker study across three cohorts (n = 1,016), we tested whether astrocyte reactivity modulates the association of Aβ with tau phosphorylation in CU individuals. We found that Aβ was associated with increased plasma phosphorylated tau only in individuals positive for astrocyte reactivity (Ast). Cross-sectional and longitudinal tau-positron emission tomography analyses revealed an AD-like pattern of tau tangle accumulation as a function of Aβ only in CU Ast individuals. Our findings suggest astrocyte reactivity as an important upstream event linking Aβ with initial tau pathology, which may have implications for the biological definition of preclinical AD and for selecting CU individuals for clinical trials.

摘要

阿尔茨海默病(AD)病理生理学的一个未解决的问题是,为什么大量淀粉样蛋白-β(Aβ)阳性认知正常(CU)个体不会发展为可检测的下游tau 病理学,从而不会出现临床恶化。体外证据表明,反应性星形胶质细胞释放 Aβ 对病理性 tau 磷酸化的影响。在这里,在三个队列(n=1016)的生物标志物研究中,我们测试了星形胶质细胞反应是否调节 CU 个体中 Aβ 与 tau 磷酸化的关联。我们发现,只有在星形胶质细胞反应阳性(Ast)的个体中,Aβ 才与血浆中磷酸化 tau 的增加相关。横断面和纵向 tau 正电子发射断层扫描分析显示,只有在 CU Ast 个体中,tau 缠结的积累呈现出 AD 样模式,这与 Aβ 有关。我们的研究结果表明,星形胶质细胞反应是将 Aβ 与初始 tau 病理学联系起来的一个重要上游事件,这可能对临床前 AD 的生物学定义以及为临床试验选择 CU 个体具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/fe9d808c6039/41591_2023_2380_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/9472e2a937d6/41591_2023_2380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/c9b7b5c455f7/41591_2023_2380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/f7c0c47499ee/41591_2023_2380_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/c9d0771c75be/41591_2023_2380_Fig4_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/fe9d808c6039/41591_2023_2380_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/9472e2a937d6/41591_2023_2380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/c9b7b5c455f7/41591_2023_2380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/f7c0c47499ee/41591_2023_2380_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/c9d0771c75be/41591_2023_2380_Fig4_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdc/10353939/fe9d808c6039/41591_2023_2380_Fig5_ESM.jpg

相似文献

1
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.星形胶质细胞反应影响了淀粉样蛋白-β对临床前阿尔茨海默病中 tau 病理的影响。
Nat Med. 2023 Jul;29(7):1775-1781. doi: 10.1038/s41591-023-02380-x. Epub 2023 May 29.
2
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's disease.星形胶质细胞反应性影响临床前阿尔茨海默病中淀粉样β蛋白和tau生物标志物的关联。
Res Sq. 2023 Feb 1:rs.3.rs-2507179. doi: 10.21203/rs.3.rs-2507179/v1.
3
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.基于生物标志物的阿尔茨海默病纵向 Tau 正电子发射断层扫描预测。
JAMA Neurol. 2022 Feb 1;79(2):149-158. doi: 10.1001/jamaneurol.2021.4654.
4
Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.皮质微结构测量与阿尔茨海默病中的淀粉样蛋白病理学有关。
Brain. 2023 Apr 19;146(4):1602-1614. doi: 10.1093/brain/awac343.
5
Higher plasma β-synuclein indicates early synaptic degeneration in Alzheimer's disease.血浆中β-突触核蛋白水平升高表明阿尔茨海默病早期突触退化。
Alzheimers Dement. 2023 Nov;19(11):5095-5102. doi: 10.1002/alz.13103. Epub 2023 Apr 27.
6
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.Tau 正电子发射断层扫描作为临床前和前驱期阿尔茨海默病预后标志物的准确性:与淀粉样蛋白正电子发射断层扫描和磁共振成像的头对头比较。
JAMA Neurol. 2021 Aug 1;78(8):961-971. doi: 10.1001/jamaneurol.2021.1858.
7
Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile.认知功能正常且 Aβ 病理负担较低的个体具有独特的 CSF 生物标志物特征。
Alzheimers Res Ther. 2021 Jul 27;13(1):134. doi: 10.1186/s13195-021-00863-y.
8
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
9
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
10
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.

引用本文的文献

1
Peripheral Inflammation Is Associated With Greater Neuronal Injury and Lower Episodic Memory Among Late Middle-Aged Adults.外周炎症与中老年晚期成年人更严重的神经元损伤及更低的情景记忆相关。
J Neurochem. 2025 Sep;169(9):e70222. doi: 10.1111/jnc.70222.
2
Astrocytic Mettl14 depletion enhances cognitive function by attenuating astrogliosis via the DUSP1/MAPK pathway in APP/PS1 mice: targeting neuroinflammation in Alzheimer's disease.在APP/PS1小鼠中,星形胶质细胞Mettl14缺失通过DUSP1/MAPK途径减轻星形胶质细胞增生,从而增强认知功能:靶向阿尔茨海默病中的神经炎症。
Mol Psychiatry. 2025 Sep 6. doi: 10.1038/s41380-025-03211-w.
3
Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum.

本文引用的文献

1
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression.阿尔茨海默病连续体中的血浆胶质纤维酸性蛋白:与其他生物标志物的关系、鉴别诊断及临床进展预测
Clin Chem. 2023 Apr 3;69(4):411-421. doi: 10.1093/clinchem/hvad018.
2
Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.血浆神经胶质纤维酸性蛋白与 18F-SMBT-1 PET 相关:两种潜在的阿尔茨海默病星形胶质细胞反应生物标志物。
J Alzheimers Dis. 2023;92(2):615-628. doi: 10.3233/JAD-220908.
3
血浆胶质纤维酸性蛋白在阿尔茨海默病连续过程中的调节作用。
Alzheimers Dement. 2025 Sep;21(9):e70626. doi: 10.1002/alz.70626.
4
Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets.神经疾病中星形胶质细胞的活性与异质性:分子机制与治疗靶点
MedComm (2020). 2025 Aug 22;6(9):e70329. doi: 10.1002/mco2.70329. eCollection 2025 Sep.
5
Clusterin Regulates the Mechanisms of Neuroinflammation and Neuronal Circuit Impairment in Alzheimer's Disease.聚集素调节阿尔茨海默病中的神经炎症机制和神经元回路损伤。
Int J Mol Sci. 2025 Jul 28;26(15):7271. doi: 10.3390/ijms26157271.
6
Circulating Biomarkers for the Early Diagnosis of Alzheimer's Disease.用于阿尔茨海默病早期诊断的循环生物标志物
Int J Mol Sci. 2025 Jul 27;26(15):7268. doi: 10.3390/ijms26157268.
7
Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non-human primate models.将神经炎症生物标志物纳入急性肾损伤(X)框架:阿尔茨海默病发病机制、诊断的进展以及非人灵长类动物模型的见解
Alzheimers Dement. 2025 Aug;21(8):e70472. doi: 10.1002/alz.70472.
8
Biomarkers and therapeutic targets in early Alzheimer's disease: an Olink proteomics study.早期阿尔茨海默病中的生物标志物与治疗靶点:一项Olink蛋白质组学研究
Front Neurol. 2025 Jul 17;16:1615152. doi: 10.3389/fneur.2025.1615152. eCollection 2025.
9
Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases.单细胞多基因风险评分剖析复杂人类疾病的细胞和分子异质性。
Nat Biotechnol. 2025 Jul 25. doi: 10.1038/s41587-025-02725-6.
10
Endothelium-specific endoglin triggers astrocyte reactivity via extracellular vesicles in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中,内皮细胞特异性内皮糖蛋白通过细胞外囊泡触发星形胶质细胞反应。
Mol Neurodegener. 2025 Jul 23;20(1):84. doi: 10.1186/s13024-025-00875-4.
Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
常染色体显性阿尔茨海默病的血浆生物标志物谱。
Brain. 2023 Mar 1;146(3):1132-1140. doi: 10.1093/brain/awac399.
4
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
5
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.淀粉样蛋白和 tau 正电子发射断层扫描(PET)阳性、认知正常的个体未来认知能力下降的风险较高。
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
6
Menopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women.绝经后血管舒缩症状与中年女性的脑白质高信号
Neurology. 2023 Jan 10;100(2):e133-e141. doi: 10.1212/WNL.0000000000201401. Epub 2022 Oct 12.
7
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.血清标志物胶质纤维酸性蛋白和神经丝轻链在认知正常老年人预后及监测中的应用:一项基于记忆门诊的前瞻性队列研究
Lancet Healthy Longev. 2021 Feb;2(2):e87-e95. doi: 10.1016/S2666-7568(20)30061-1. Epub 2021 Jan 19.
8
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.血浆 p-tau231 和 p-tau217 作为临床前阿尔茨海默病淀粉样β病理的状态标志物。
Nat Med. 2022 Sep;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w. Epub 2022 Aug 11.
9
Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.血浆 p-tau181 与阿尔茨海默病生物标志物、认知衰退和临床进展的性别差异。
Mol Psychiatry. 2022 Oct;27(10):4314-4322. doi: 10.1038/s41380-022-01675-8. Epub 2022 Jun 29.
10
Characterizing Amyloid-Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.5 年后 Tau PET 正常的淀粉样蛋白阳性个体特征:ADNI 研究。
Neurology. 2022 May 31;98(22):e2282-e2292. doi: 10.1212/WNL.0000000000200287. Epub 2022 Mar 21.